Day: July 12, 2021

Posted on

CNH Industrial announces senior Bus leadership appointment in new On-Highway busines

London, July 12, 2021

Further to the recent announcements for its On-Highway business, which is expected to begin operations in early 2022, CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces the following appointment: Domenico Nucera will head the Bus Business Unit, succeeding Sylvain Blaise, effective October 1, 2021.

Mr. Nucera has some 20 years of experience in the automotive industry, with a strong industrial background and roles of increasing responsibility on the business and manufacturing fronts. He served in the Powertrain Manufacturing function and, following his successful direction of FPT Industrial’s Turin Driveline and Engine plants, was promoted to Head of Quality and Product Support for Powertrain. He is currently responsible for Quality Powertrain and Head of Aftermarket Solutions for both Powertrain and Commercial & Specialty Vehicles.

“I would like to congratulate Domenico on this appointment. His broad qualifications, focus on customer service and work acumen have seen him prove himself as a capable and versatile manager, who understands how to address the needs of customers together with the demands of the shop floor,” said Gerrit Marx, designated CEO of the new On-Highway business.

“And to Sylvain Blaise, I want to thank you again for the tremendous work that you have done in taking our bus business forward during such a transformational moment for the mass transit sector. We are pleased to confirm that Sylvain will continue to represent our future Company in France, a key market in which we have been present for over a century with a pioneering role in public transport – where we are the current market leader – and in which the On-Highway business continues to foster a strong manufacturing and innovation footprint.”

CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) is a global leader in the capital goods sector with established industrial experience, a wide range of products and a worldwide presence. Each of the individual brands belonging to the Company is a major international force in its specific industrial sector: Case IH, New Holland Agriculture and Steyr for tractors and agricultural machinery; Case and New Holland Construction for earth moving equipment; Iveco for commercial vehicles; Iveco Bus and Heuliez Bus for buses and coaches; Iveco Astra for quarry and construction vehicles; Magirus for firefighting vehicles; Iveco Defence Vehicles for defence and civil protection; and FPT Industrial for engines and transmissions. More information can be found on the corporate website: www.cnhindustrial.com

Media contact:

Corporate Communications

Email: mediarelations@cnhind.com

Investor Relations

Email: investor.relations@cnhind.com

Attachment

 

Posted on

Epicor Survey Finds Supply Chain Digital Acceleration is Critical to Fruitful Post-Pandemic Economy

As Tech Early Adopters, Midsize Organizations Predict Growth and Job Creation will Follow as 94% of Respondents Plan Cloud Adoption in 2021

Las Vegas, Nevada, July 12, 2021 (GLOBE NEWSWIRE) — News summary:

  • Cloud prioritization among midsize essential businesses accelerated from 25% consideration in 2020, to 94% adopting cloud this year.
  • 75 percent expect their business to be fully recovered from the impact of COVID-19 by 2022, 61% expect to expand in size and scale over the coming three years and 55% expect to create new jobs.

Epicor Software Corporation, a global provider of industry-specific enterprise software, today presented the findings from their annual Insights Report. The key takeaway is that leaders of midsize businesses across the supply chain are bullish about growth fuelled on investment in cloud-ready technologies.

The study exclusively surveys leaders from midsize1 businesses across the manufacturing, distribution and retail industries on the drivers of business growth over the coming year. The survey finds the nation’s most essential business leaders are not simply gearing up for a ‘bounce back’ year but rather, they are leaning into the accelerating forces of COVID-19 to ‘leap forward.’ The most significant indicator of progress is the radical swing in cloud adoption. In 2020, 25% of respondents declared cloud a strategic priority. In this year’s study, 99% of those surveyed confirmed they plan to move to the cloud, and 94% of them intend to do so this year.

“A key takeaway from this year’s study is the sea change in attitude toward cloud as a critical business accelerant. Leaders have moved from consideration to adoption. While the companies who make, move, and sell what is most essential to economic growth may be all aboard the cloud train, the data suggests their implementation needs vary vastly,” stated Steve Murphy, CEO Epicor Software Corporation, during his keynote address at the annual customer Insights conference. He added: “This is no longer a ‘why move’ conversation but rather a ‘how to move’ to gain advantage – which is exactly why Epicor will continue to prioritize partnership, and we are proud to share that our dedicated migration teams currently support over 75% of implementations, a number we expect to grow.”

Recognizing we have a vital role to play in supporting these essential businesses, Epicor prioritizes initiatives to address the needs and concerns of its customer base including, cybersecurity, implementation-as-a-service, total cost of ownership, and connectivity equity (read the blog post here).

The survey focuses on bringing to the forefront the voices of the essential businesses that keep the world turning and provides opinion from across the supply chain landscape. While the overwhelming message of digital acceleration is encouraging for the nation’s economic recovery and future growth, the data does provide signposts for the IT industry around the support these midsize essential businesses need to thrive. The full report can be accessed at epicor.com/industry, along with the summary fact sheet.

Survey Methodology

PSB conducted an online survey among n=1,250 IT decision-makers in the U.S. and the UK n=1,000 were based in the U.S. The interviews were conducted in English from February 22 to March 11, 2021.

The margin of error for the total sample is +/-2.77ppts and larger for sub-groups.

About Epicor Software Corporation

Epicor Software Corporation equips hard-working businesses with enterprise solutions that keep the world turning. For nearly 50 years, Epicor customers in the automotive, building supply, distribution, manufacturing, and retail industries have trusted Epicor to help them do business better. Epicor’s innovative solution sets are carefully curated to fit customer needs and built to respond flexibly to their fast-changing reality. With deep industry knowledge and experience, Epicor accelerates every customer’s ambitions, whether to grow and transform, or simply become more productive and effective. Visit www.epicor.com for more information.

1 Decision-makers from midsize companies are representative of the manufacturing, distribution, and retail sectors with revenues between $20 million and $250 million were interviewed in March 2021.

Attachments

Raelle Alfaro
Epicor Software
raelle.alfaro@epicor.com
Posted on

Tech Giants to Donate COVID Vaccines to Taiwan in China Workaround

Taiwanese tech giants Foxconn and Taiwan Semiconductor Manufacturing Company announced Monday they will each donate five million coronavirus vaccine doses to the government in a deal with a China-based distributor.

Taipei has been struggling to secure enough vaccines for its population, and its precarious political status has been a major stumbling block.

As Taipei and Beijing accused each other of hampering vaccine deals, Foxconn and TSMC stepped in with a face-saving solution — buying the Pfizer-BioNTech doses from a Chinese distributor and donating them to Taiwan.

“Me and my team feel the public anxiety and expectations on the vaccines and we are relieved to give the public an answer that relevant contracts have been signed,” Foxconn founder Terry Gou said in a post on his Facebook page.

“Beijing authorities have not offered any guidance or interfered with the vaccine acquisition process,” he said, adding that the vaccines will be shipped directly by German firm BioNTech.

Foxconn and TSMC, the world’s largest contract electronics and chip makers respectively, said they will spend $175 million each on the vaccines.

Beijing’s authoritarian leadership views democratic self-ruled Taiwan as part of China’s territory and has vowed to one day seize the island, by force if needed.

China tries to keep Taiwan internationally isolated, including blocking it from the World Health Organization.

Taipei has been trying to secure Pfizer-BioNTech direct from Germany, but Shanghai-based Fosun Pharma has the distribution rights for China, Hong Kong, Macau and Taiwan.

Attempts to sign a direct deal made little headway, something Taiwan blamed on Beijing.

In return, Beijing has accused Taiwan of refusing to deal with Fosun Pharma and politicizing its vaccine search.

Fosun issued a statement late Sunday saying it had signed a deal with the Taiwanese firms to sell 10 million shots, to be donated to “disease control institutions in the Taiwan region.”

In an interview with China’s Global Times — a state-run tabloid — Fosun Chairman and CEO Wu Yifang accused Taipei of “rule-breaking in the whole process.” No further elaboration was provided.

Taiwan had only received 726,000 vaccine doses before the United States and Japan recently donated 2.5 million and 2.37 million doses, respectively.

So far, just 14 percent of its 23.5 million people have been vaccinated, according to the health ministry.

Health Minister Chen Shih-chung previously revealed that Taiwan and BioNTech were about to finalize a deal in January when the company suggested the words “our country” had to be taken out of a Taiwanese press statement.

Chen said authorities agreed to replace it with “Taiwan,” but the deal remained stalled.

The Chinese government reacts angrily at any attempts to recognize Taiwan as an independent nation.

Source: Voice of America

Posted on

India’s Daily COVID Infections Fall Below 40,000

India’s daily tally of new COVID cases fell below 40,000 on Sunday. The health ministry reported Monday that there were 37,154 new cases in the previous 24-hour period.

In South Korea, the country reported 1,100 new cases Sunday. The rising caseload comes as South Korea is imposing new restrictions in Seoul and neighboring regions to curb the spread of infections.

Meanwhile in Uganda, Chris Baryomunsi, a government minister said his country has the money to buy vaccines but is having trouble purchasing them from Western countries.

“This is a challenge of access and equity,” Baryomunsi, who is also an epidemiologist, told the Guardian newspaper. “We have the money, but we simply can’t get the vaccine . . . we have to rely on the western world and the western world has focused on its population. The impression is that people there don’t care about Africans.”

Last week, the World Health Organization Director-General Tedros Adhanom Ghebreyesus spoke at the University of Nottingham about the global health disparities the pandemic has exposed. “At the global level, the pandemic has revealed a profound gap, a deficit of solidarity and sharing: the sharing of critical data, sharing of epidemiological information, sharing of resources, technology and tools that every nation needs to keep its people safe.”

The WHO chief said, “We have to learn the lessons of COVID-19. Because it is unprecedented. This pandemic has thrived amid the inequalities and inequities in our societies and exploited the gaps in our health systems. It has exacerbated the disparities between and within countries. As we speak, rich countries are vaccinating their populations while much of the rest of the world is left to watch and wait. And we see the inequity, the injustice. More than 70 percent of all vaccines have been administered in just ten countries.”

As much of the world struggles to vaccinate their populations, Pfizer, the biopharmaceutical company that makes one of the vaccines, says it is time to consider a booster shot to protect against the more contagious variants of the coronavirus. But U.S. Centers for Disease Control and Prevention and the Federal Drug Administration said Friday they don’t believe Americans need another shot yet.

Pfizer said that some of its representatives would meet with officials at the FDA on Monday. The company had said recently that booster shots would be needed within the next 12 months.

Dr. Anthony Fauci acknowledged that booster shots may be needed but said Sunday that it was too soon for the government to recommend another shot. Roughly half of the U.S. population has been fully vaccinated.

The Johns Hopkins Coronavirus Resource Center reported more than 186 million global COVID infections early Monday and more than 4 million global deaths. The U.S. has the most cases with 33.9 million, followed by India with 30.9 million.

Johns Hopkins reported 3.4 billion vaccines have been administered worldwide.

Source: Voice of America